Moderate Evidence
Research Overview
Hexarelin Research for Growth Hormone Stimulation
An evidence-based overview of research examining Hexarelin in the context of growth hormone stimulation. This page synthesizes findings from peer-reviewed literature.
Research Summary
Hexarelin is the most potent synthetic GHRP for acute GH release. Human studies showed GH responses approximately 2x greater than GHRP-6. However, rapid desensitization (50-80% reduction within 4-7 days) ended pharmaceutical development for chronic use.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Growth Hormone Stimulation
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Hexarelin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.